GIM
SCMP

Guild Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Guild Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-80,553
Closed -$576K – 44
2014
Q1 		$576K Buy
+80,553
New +$689K 0.96% 21

Other funds holding SCMP

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Guild Investment Management's SCMP Position: Q2 2014 in Review

Guild Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2014, closing a stake of 80,553 shares — an estimated $576K sold.

Guild Investment Management first reported a position in SCMP in Q1 2014 and held it in 1 quarter. The position peaked at $576K in Q1 2014. 71 funds tracked by Wall St. Rank hold SCMP as of Q2 2014.

  • Guild Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Guild Investment Management sold 80,553 Sucampo Pharmaceuticals, Inc. shares in Q2 2014, an estimated $576K.
  • Guild Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2014 and held it in 1 quarter.
  • Guild Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $576K in Q1 2014.
  • 71 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2014.

Based on Guild Investment Management's 13F filing for Q2 2014, filed 1 Aug 2014.